Thank you for taking time & visiting us on our new and improved website. As we are on the path towards rapid global pharmaceutical industry evolution, MSN as a company is constantly in the path of realigning and streamlining our business objectives to achieve desired results. As dynamic and demanding market has become the new global norm, I see promising opportunities for MSN Group in the years ahead.Read More
One of the fastest growing pharmaceutical companies in the country, MSN Laboratories has nine API facilities, including oncology.
We have exemplified complex drug development that is economically feasible - making MSN Laboratories World No. 1 in active DMFs.
MSN group has been a pivotal provider with a record of 25 first to file ANDA’s and 17 First in World Generics.